BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 18547539)

  • 1. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH; Chen MS
    Am J Ophthalmol; 2008 Aug; 146(2):211-217. PubMed ID: 18547539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
    Yeh PT; Yang CH; Yang CM
    Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
    Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
    Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage.
    Cheema RA; Mushtaq J; Al-Khars W; Al-Askar E; Cheema MA
    Retina; 2010; 30(10):1646-50. PubMed ID: 20634777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
    Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
    Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.
    Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC
    Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
    Ahn J; Woo SJ; Chung H; Park KH
    Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
    Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
    Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy.
    Yeh PT; Yang CM; Lin YC; Chen MS; Yang CH
    Retina; 2009 Jun; 29(6):768-74. PubMed ID: 19516117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage: a prospective randomized control study.
    Patwardhan SD; Azad R; Shah BM; Sharma Y
    Retina; 2011 May; 31(5):866-70. PubMed ID: 21301382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage.
    Farahvash MS; Majidi AR; Roohipoor R; Ghassemi F
    Retina; 2011; 31(7):1254-60. PubMed ID: 21499192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study.
    Jirawison C; Ittipunkul N
    J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S136-42. PubMed ID: 22696866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage.
    Huang YH; Yeh PT; Chen MS; Yang CH; Yang CM
    Retina; 2009 Sep; 29(8):1134-40. PubMed ID: 19672218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage.
    Berk Ergun S; Toklu Y; Cakmak HB; Raza S; Simsek S
    Semin Ophthalmol; 2015 May; 30(3):177-80. PubMed ID: 24409948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?
    Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
    Eye (Lond); 2009 Aug; 23(8):1698-701. PubMed ID: 19039332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Manabe A; Shimada H; Hattori T; Nakashizuka H; Yuzawa M
    Retina; 2015 Sep; 35(9):1800-7. PubMed ID: 25932549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
    di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab (Avastin) in proliferative diabetic retinopathy.
    Minnella AM; Savastano CM; Ziccardi L; Scupola A; Falsini B; Balestrazzi E
    Acta Ophthalmol; 2008 Sep; 86(6):683-7. PubMed ID: 17995986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.